KRT18 and metabolic dysfunction-associated steatohepatitis: In order to increase the accuracy of the diagnosis of NASH, Chuah et al. [99] combined CK-18, aspartate aminotransferase (AST), and a homeostasis model assessment (HOMA), which led to the MACK-3 panel with better results.